CONCLUSION: The paediatric-pharmacy shared-care model was associated with shorter wait times, greater cost-efficiency, and redistribution of routine medication reviews to pharmacists, with increased overall review frequency despite fewer medical appointments per patient. Pharmacist reviews were comprehensive and delivered within a supervised framework. These findings support pharmacist-led shared care as a scalable strategy to improve access and workforce capacity in developmental paediatrics.
